FDA Adverse Event Malfunction Summary report: N

LSLF EXT SET W CLV

MDR report key: 2180672 · Received May 5, 2011

Report

Report Number
9613251-2011-00078
Event Type
Malfunction
Date Received
May 5, 2011
Date of Event
April 1, 2011
Report Date
April 19, 2011
Manufacturer
HOSPIRA, LTD
Product Code
FPK
PMA / PMN Number
K941214
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS IS A KNOWN ISSUE AND NO EVAL WILL BE PERFORMED ON THE CUSTOMER'S DEVICE. THE ISSUE OF SPLIT OR BURST TUBING WHEN USING POWER INJECTORS WAS EVALUATED UNDER A FORMAL INVESTIGATION. IT WAS DETERMINED THAT THIS IS NOT A MFG OR MATERIALS DEFECT. IT WAS COMMUNICATED TO THE CUSTOMER THAT STANDARD I.V. ADMINISTRATION SETS ARE INTENDED FOR GENERAL INFUSION AND NOT RECOMMENDED FOR USE WITH POWER INJECTORS. PRODUCT LABELING FOR THIS DEVICE STATES, "CAUTION: NOT FOR HIGH PRESSURE INFUSION." THIS REPORT REPRESENTS ALL THE INFO KNOWN BY THE RPTR UPON QUERY BY HOSPIRA PERSONNEL.

Description of Event or Problem · 1

GENERAL REPORT REC'D OF AN UNSPECIFIED NUMBER OF UNDOCUMENTED INCIDENTS OF TUBING RUPTURES WHILE IN USE WITH POWER INJECTORS; SUBSEQUENTLY BLOOD LOSS WAS NOTED. DURING CT SCANS, THE TUBING SETS WERE BEING USED TO DELIVER UNSPECIFIED VOLUMES OF OMNIPAQUE 300 CONTRAST MEDIUM AT A RATE OF 3ML/SEC VIA A MEDRAD POWER INJECTOR. IT WAS REPORTED THAT IMMEDIATELY AFTER THE DELIVERIES STARTED, THE TUBINGS RUPTURED AT UNSPECIFIED LOCATIONS. UNSPECIFIED VOLUMES OF BLOOD WERE LOST. THE TUBINGS WERE CLAMPED USING THE SLIDE CLAMPS. THE TUBING SETS WERE REPLACED AND THE PROCEDURES WERE RESUMED. THERE WERE NO REPORTED ADVERSE PT EFFECTS AND NO REPORTED DELAYS OF THERAPY CRITICAL TO THESE PTS. NO MEDICAL INTERVENTIONS WERE REQUIRED. THOUGH REQUESTED, NO ADD'L INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LSLF EXT SET W CLV 80FPK FPK HOSPIRA, LTD NA UNKNS

Patients

Seq Age Sex Outcome Treatment
1 UNSPECIFIED POWER INJECTOR, MANUFACTURED BY| MEDRAD, INC.| OMNIPAQUE 300, MANUFACTURED BY GE HEALTHCARE, INC.